Briacell Therapeutics Corp (BCTX)

Finanzdaten der Briacell Therapeutics Corp-Aktie (BCTX)

*Alle Zahlen in Millionen

Enddatum des Zeitraums	2026-07-31	2026-04-30	2026-01-31	2025-10-31	2025-07-31
Periodenlänge	3 Monate	3 Monate	3 Monate	3 Monate	3 Monate
	65.06%12.58	7.62	7.53	8.32	8.55
Research and Development	76.52%10.53	5.97	6.05	6.68	7.11
Operating Income/Loss	65.06%-12.58	-7.62	-7.53	-8.32	-8.55
Nonoperating Income/Loss	8.40%0.17	0.19	0.08	0.16	0.05
Income/Loss From Equity Method Investments	43.62%-0.09	-0.06	-0.06	-0.04	-0.05
	72.90%-12.51	-7.24	-7.30	-8.28	-8.16
Attributable To Parent	71.96%-12.32	-7.16	-7.22	-8.20	-8.09
Attributable To Noncontrolling Interest	165.54%-0.19	-0.07	-0.08	-0.08	-0.07